Site & patient solutions case studies

Explore our library of case studies for patient centric clinical trial services.

An end-to-end solution providing the support and structure to efficiently operationalise clinical trials. Site & Patient Solutions offers faster study start-up, increased patient enrolment and retention, and site training and support to ensure compliance, quality data and inspection readiness.

In-Home Services: Trial continuity during COVID-19

A biopharmaceutical company was running a global 4-study program evaluating the long-term safety and effectiveness of a study drug in adult patients with a rare, inherited disease impacting the kidneys and other vital organs.

In-Home Services: Patient satisfaction levels in rare disease

Large pharmaceutical company was running a phase II study to assess the efficacy of a study drug in paediatric patients with a rare degenerative genetic disorder. The study required weekly infusions for more than 50 patients in the UK.

In-Home Services: Special populations and procedures

A global biopharmaceutical company was conducting a set of post-marketing studies to determine the safety and transference of a drug taken for autoimmune disorders during pregnancy and breastfeeding.

In-Home Services: Expanding geographic reach

A small pharmaceutical company was conducting a Phase II study to evaluate the safety, efficacy and tolerability of an oral study drug to be taken twice daily. The study was targeting 32 adult patients (16-60 years old) with an inherited rare neurodegenerative movement disorder.

In-Home Services: Enhanced patient retention

A biopharmaceutical company ran multiple Phase II/III orphan drug studies evaluating a drug for a rare pulmonary disorder. The treatment regimen required daily oral dosing and safety blood draws every 2 weeks with a treatment duration of up to 2 years.

In-Home Services: Patient centric practices

Accellacare was contracted by a large pharma organisation to recruit and provide In-Home Services to paediatric patients with autism.

Agile operations drive enrollment in COVID-19 treatment studies

ICON’s Accellacare In-Home Services were used across more than 50 sites in the United States to conduct blood draws and nasal swabs, collect vital signs, and monitor for changes in health, medications, or hospitalisation for a two treatment studies in patients with COVID-19.